Topic

Helixate (antihemophilic factor, rFVIII)

A collection of 35 issues

How to Get Helixate (antihemophilic factor, rFVIII) Covered by Aetna CVS Health in Ohio: Complete Prior Authorization and Appeals Guide 2024

Quick Answer: Getting Helixate (antihemophilic factor, rFVIII) Covered by Aetna CVS Health in Ohio Aetna CVS Health requires prior authorization for Helixate (antihemophilic factor, rFVIII) in Ohio. Submit your PA request through your hematologist with complete hemophilia A documentation, including factor VIII levels <1% (severe) or 1-5% (moderate), bleed

Do You Qualify for Helixate Coverage by Aetna CVS Health in Illinois? Decision Tree & Next Steps

Answer Box: Getting Helixate Covered by Aetna CVS Health in Illinois Helixate (antihemophilic factor, rFVIII) requires prior authorization with Aetna CVS Health and is typically covered for confirmed hemophilia A when medically necessary. Note: Kogenate FS was discontinued in 2022-2023, so patients need alternatives like Kovaltry, Jivi, or other factor

Getting Helixate (rFVIII) Covered by Blue Cross Blue Shield in Washington: Complete Appeals Guide with State Protections

Quick Answer: Your Path to Coverage Getting Helixate (antihemophilic factor, rFVIII) covered by Blue Cross Blue Shield in Washington requires navigating prior authorization, potential step therapy, and Washington's strong external review protections. Start with a formulary exception request through your plan's pharmacy services, backed by detailed

How to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Aetna CVS Health in Michigan: Complete Coverage Guide with Appeals Process

Quick Answer: Getting Helixate Covered by Aetna CVS Health in Michigan Important Update: Helixate (antihemophilic factor, rFVIII) has been discontinued by the manufacturer. Aetna CVS Health now covers alternative factor VIII products like Kovaltry, Advate, and Jivi with prior authorization. First step: Contact your hematologist to select an alternative and

How to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Blue Cross Blue Shield in New York: Complete PA and Appeals Guide

Answer Box: Getting Helixate Covered in New York Helixate (antihemophilic factor, rFVIII) requires prior authorization from Blue Cross Blue Shield in New York. Submit PA requests via the Availity ICR portal or fax 1-844-493-9206. If denied, file an internal appeal within 65 days, then pursue external review through NY Department

How Long Does It Take to Get Helixate (Antihemophilic Factor, rFVIII) Approved by UnitedHealthcare in Michigan? Complete Timeline & Approval Guide

Answer Box: Getting Helixate Approved by UnitedHealthcare in Michigan Important Note: Helixate FS and Kogenate FS were discontinued in 2022-2023. Current patients need alternative factor VIII products like Kovaltry or Jivi, which follow similar approval timelines. Fastest Path: Standard prior authorization takes 15 days, expedited review 72 hours for urgent

How Long Does It Take to Get Helixate (Antihemophilic Factor) Approved by Humana in Michigan? Timeline & Milestones

Answer Box: Quick Timeline Overview Helixate (antihemophilic factor, rFVIII) is no longer manufactured, but similar factor VIII products require prior authorization from Humana Medicare plans in Michigan. Standard review takes up to 30 days (shortening to 7 days in 2026), while expedited requests are decided within 72 hours. If denied,

How to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Timeline and Appeals Guide

Answer Box: Getting Helixate Covered in Pennsylvania Important Update: Helixate NexGen and related Kogenate FS have been discontinued by Bayer. Blue Cross Blue Shield Pennsylvania plans now require prior authorization for alternative factor VIII products like Kovaltry, Advate, or Jivi. The fastest path to approval: (1) Have your hematologist submit

How to Get Helixate (Antihemophilic Factor VIII) Covered by Aetna CVS Health in Florida: Complete Prior Authorization Guide

Quick Start: Getting Helixate Covered by Aetna CVS Health in Florida Important Note: Helixate (Kogenate FS) was discontinued in the U.S. market in 2022-2023. Aetna CVS Health now requires transition to alternative recombinant factor VIII products like Advate, Kovaltry, or Jivi. Step 1: Contact your hematologist to select an

If Helixate (Antihemophilic Factor, rFVIII) Isn't Approved by Cigna in Virginia: Formulary Alternatives & Exception Paths

Answer Box: Your Next Steps When Cigna Denies Helixate (rFVIII) When Cigna denies Helixate (antihemophilic factor, rFVIII) in Virginia, you have two main paths: switch to a formulary alternative or file a formulary exception. Most Cigna plans now list Helixate as non-formulary, requiring trial of preferred products like Advate, Kovaltry,